Novita Pharmaceuticals
Phase 2Novita is dedicated to developing first-in-class drugs to boost anti-cancer immune responses and to prevent and treat cancer metastasis.
Founded
2010
Focus
Small Molecules
About
Novita is dedicated to developing first-in-class drugs to boost anti-cancer immune responses and to prevent and treat cancer metastasis.
Company Info
TypePrivate
Founded2010
LocationSan Diego, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile